Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insight Molecular Diagnostics (IMDX) Other Working Capital Changes: 2020-2025

Historic Other Working Capital Changes for Insight Molecular Diagnostics (IMDX) over the last 6 years, with Sep 2025 value amounting to -$65,000.

  • Insight Molecular Diagnostics' Other Working Capital Changes fell 113.66% to -$65,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $229,000, marking a year-over-year increase of 7.01%. This contributed to the annual value of $458,000 for FY2024, which is 158.42% up from last year.
  • According to the latest figures from Q3 2025, Insight Molecular Diagnostics' Other Working Capital Changes is -$65,000, which was down 152.42% from $124,000 recorded in Q2 2025.
  • Over the past 5 years, Insight Molecular Diagnostics' Other Working Capital Changes peaked at $1.1 million during Q1 2021, and registered a low of -$1.0 million during Q2 2021.
  • For the 3-year period, Insight Molecular Diagnostics' Other Working Capital Changes averaged around -$18,364, with its median value being -$27,000 (2024).
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first slumped by 695.38% in 2021, then skyrocketed by 710.26% in 2024.
  • Quarterly analysis of 5 years shows Insight Molecular Diagnostics' Other Working Capital Changes stood at -$1.0 million in 2021, then soared by 49.31% to -$514,000 in 2022, then spiked by 72.96% to -$139,000 in 2023, then soared by 175.54% to $105,000 in 2024, then plummeted by 113.66% to -$65,000 in 2025.
  • Its Other Working Capital Changes was -$65,000 in Q3 2025, compared to $124,000 in Q2 2025 and $65,000 in Q1 2025.